Literature DB >> 10634831

Should cisapride have been "blacklisted"?

M Markiewicz1, Y Vanden Plas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10634831      PMCID： PMC1721037          DOI： 10.1136/fn.82.1.f3

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  11 in total

Review 1.  The use of cisapride in children. The North American Society for Pediatric Gastroenterology and Nutrition.

Authors:  R J Shulman; J T Boyle; R B Colletti; R A Friedman; M B Heyman; G Kearns; B S Kirschner; J Levy; A A Mitchell; G Van Hare
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-05       Impact factor: 2.839

Review 2.  Cisapride toxicosis in dogs.

Authors:  P A Volmer
Journal:  Vet Hum Toxicol       Date:  1996-04

3.  Surgical treatment of gastroesophageal reflux in children: a combined hospital study of 7467 patients.

Authors:  E W Fonkalsrud; K W Ashcraft; A G Coran; D G Ellis; J L Grosfeld; W P Tunell; T R Weber
Journal:  Pediatrics       Date:  1998-03       Impact factor: 7.124

Review 4.  Cisapride. Drug interactions of clinical significance.

Authors:  T A Bedford; D J Rowbotham
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

5.  The risks and benefits of cisapride in premature neonates, infants, and children.

Authors:  A Lander; A Desai
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

6.  The QT interval throughout the first 6 months of life: a prospective study.

Authors:  P J Schwartz; M Montemerlo; M Facchini; P Salice; D Rosti; G Poggio; R Giorgetti
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

Review 7.  Clinical use of cisapride and its risk-benefit in paediatric patients.

Authors:  Y Vandenplas
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-10       Impact factor: 2.566

Review 8.  A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN).

Authors:  Y Vandenplas; A Ashkenazi; D Belli; N Boige; J Bouquet; S Cadranel; J P Cezard; S Cucchiara; C Dupont; K Geboes
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

9.  Cisapride: a survey of the frequency of use and adverse events in premature newborns.

Authors:  R M Ward; J A Lemons; R A Molteni
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

10.  Effect of cisapride on postprandial gastro-oesophageal reflux.

Authors:  R H Holloway; J Downton; B Mitchell; J Dent
Journal:  Gut       Date:  1989-09       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.